Filter
690
Text search:
epilepsy
Featured
Recommendations
89
New Publications
137
Language
Document type
No document type
484
Guidelines
68
Studies & Reports
58
Manuals
39
Training Material
17
Strategic & Response Plan
13
Fact sheets
7
Resource Platforms
3
Situation Updates
1
Countries / Regions
India
36
South Africa
27
Kenya
21
Uganda
18
Sierra Leone
16
Malawi
16
Ethiopia
15
Zambia
13
Liberia
12
Nepal
12
Global
12
Nigeria
10
Bangladesh
9
Ghana
8
Ukraine
8
Syria
7
Lesotho
7
Tanzania
6
Latin America and the Carribbean
6
Africa
6
Eastern Europe
6
Russia
6
South Sudan
5
Cambodia
5
Rwanda
5
Mozambique
5
Western and Central Europe
5
Asia
5
Zimbabwe
4
South–East Asia Region
4
Congo, Democratic Republic of
3
Cameroon
3
Namibia
3
Eswatini/ Swaziland
3
Botswana
3
Myanmar / Burma
3
Chile
3
Burkina Faso
2
Senegal
2
Haiti
2
Philippines
2
Pakistan
2
Afghanistan
2
China
2
Indonesia
2
Sudan
2
North Macedonia
2
Sri Lanka
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Kazakhstan
2
Mali
1
USA
1
Germany
1
Turkey
1
Egypt
1
Thailand
1
Malaysia
1
Brazil
1
Colombia
1
Mexico
1
Yemen
1
East and Southern Africa
1
Fiji
1
Venezuela
1
Palestine
1
Laos
1
Lithuania
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
244
Clinical Guidelines
45
Public Health
36
Women & Child Health
21
Capacity Building
12
Key Resources
7
Pharmacy & Technologies
1
Toolboxes
Mental Health
214
Disability
132
NTDs
25
Pharmacy
23
Caregiver
15
Planetary Health
13
NCDs
9
Conflict
8
Zika
8
Ebola & Marburg
7
Refugee
7
TB
7
Global Health Education
7
COVID-19
7
Natural Hazards
5
Rapid Response
5
HIV
5
AMR
4
Malaria
3
2.0 Rapid Response
3
Cholera
1
Specific Hazards
1
What you can do
Q11: 11a). In women with epilepsy, should antiepileptic therapy be prescribed as monotherapy or polytherapy to decrease the risk of fetal malformations?
11b). Does the use of folic acid preconceptually decrease the risk of foetal malformations in w
...
Out of the shadows
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
Neurology Asia 2008; 13 : 41 – 48
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
Epilepsia, 55(4):475–482, 2014
doi: 10.1111/epi.12550
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Q 7: For adults and children with convulsive epilepsy, which standard antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, valproic acid) when compared to placebo/a comparator produce benefits/harm in the specified outcomes?
Arq Neuropsiquiatr 2011;69(2-B):342-348
DAKAR, le 06 Mai 2000
Low- and middle-income countries (LMICs) experience a high disease burden for epilepsy, a chronic neurological condition.The authors evaluate the cost-effectiveness of community health workers (CHWs) to improve adherence to medication for
...
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Primary Care 101
recommended
Symptom-based integrated approach to the adult in primary care.
Primary Care 101 is a comprehensive clinical practice guideline that aims to equip nurses and other clinicians to diagnose and manage common adult conditions at primary level.
Tb; HIV; Asthma/COPD; cardiovascular disease; diabetes; M
...
Published OnlineJuly 14, 2021https://doi.org/10.1016/S2214-109X(21)00164-9. New Lancet research offers the first comprehensive analysis of the growing footprint of noncommunicable and injury-related neurological disorders to India’s overall disease burden.
Takeaways from 1990 to 2019 In terms
...